Product logins

Find logins to all Clarivate products below.


Facial Injectables | Latin America (Supplemental) | 2016 | Market Analysis

The Latin American market for facial injectables will face somewhat limited procedure volume growth in the short term due to a combination of pricing pressures, poor economic conditions, and low market penetration in some regions. However, as these conditions are alleviated over the forecast period, the market will experience strong growth through 2024.

This Medtech 360 Report provides key market metrics and high-level qualitative commentary for the facial injectable market in Latin America, including country-level data for seven major countries and aggregate data for the rest of Latin America, across a 10-year period.

Related Medtech Insights Reports

Report
Aesthetic Injectables – Market Insights – Latin America
The Latin American aesthetic injectables market will expand through 2035, driven by ongoing product innovation and differentiation strategies among key competitors, as well as the increasing…
Report
Laparoscopic Devices – Market Insights – Latin America
The Latin American laparoscopic device market will experience steady moderate growth through 2035, supported by the gradual expansion of MIS volumes and selective adoption of highervalue…
Report
Aesthetic Injectables – Market Insights – Middle East
The Middle Eastern aesthetic injectable market will see strong growth, driven by the rising awareness and acceptability of these procedures due to the growing influence of social media, as well as…
Report
Urological Devices – Market Insights – Latin America
The Latin American urological device market will continue to expand through 2034, driven by the rising prevalence of kidney stones and UI, aging populations, and growing patient awareness of…
Report
Interventional Oncology Devices – Market Insights – Latin America
The Latin American interventional oncology device market will see moderate growth through 2034, driven by a large and rapidly expanding patient pool, improving access to treatment, and the entry of…